Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech failure, 2002 -- Ignore unavailable to you. Want to Upgrade?

To: Elmer who wrote (53)	4/26/2002 9:04:37 AM
From: dalroi	Respond to of 130

Reuters Business Cellegy Withdraws Pain Drug Application SOUTH SAN FRANCISCO, Calif. (Reuters) - Cellegy Pharmaceuticals Inc. (NasdaqNM:CLGY - news) on Friday said it has withdrawn the New Drug Application for its Cellegesic pain ointment. The company said it made the decision after a recent meeting with the U.S. Food and Drug Administration, "during which it became clear that the agency would require additional information in order to grant marketing clearance" in the United States." The drug's nitroglycerin ointment is intended for the treatment of pain associated with chronic anal fissures. Cellegy said it remains confident in the drug and said it plans to meet again soon with the agency to discuss the type of additional information needed.